Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 2005, p. 5123-5126, Vol. 49, No. 12
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.12.5123-5126.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan,1 Department of Molecular Behavioral Biology, Osaka Bioscience Institute, Osaka 565-0874, Japan,2 United States Army Medical Research Unit-Kenya, Unit 64109, APO AE 09831-64109, Kenya,3 Tsukuba Medicinal Plant Research Station, National Institute of Health Sciences, Tsukuba 305-0843, Japan,4 Department of Molecular and Cellular Parasitology, Juntendo University School of Medicine, Tokyo 113-8421, Japan,5 Department of Material and Life Science, Graduate School of Engineering, Osaka University, SORST, JST, Osaka 565-0871, Japan,6 Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kyoto 610-0395, Japan7
Received 14 June 2005/ Returned for modification 22 July 2005/ Accepted 20 September 2005
A novel potent trypanocidal diterpene, komaroviquinone, was reduced by Trypanosoma cruzi old yellow enzyme (TcOYE) to its semiquinone radical. The reductase activity in trypanosome lysates was completely immunoabsorbed by anti-TcOYE antibody. Since TcOYE is expressed throughout the T. cruzi life cycle, komaroviquinone is an interesting candidate for developing new antichagasic drugs.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»